Skip to content
Biodatica
Start free

Investigator

Mitchell J Weiss

ST. JUDE CHILDREN'S RESEARCH HOSPITAL · funded by NHLBI

Companies
1

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$2.9M

Summed across those awards.

First award
Jan 1, 2021

Latest Sep 1, 2023.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U01

    Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease

    $1.2M

    Sep 1, 2023NHLBIST. JUDE CHILDREN'S RESEARCH HOSPITALNIH RePORTER · 11166450 (opens the source filing in a new tab)

  2. U01

    Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease

    $185k

    Sep 1, 2023NHLBIST. JUDE CHILDREN'S RESEARCH HOSPITALNIH RePORTER · 11378801 (opens the source filing in a new tab)

  3. R01

    ULK-mediated autophagy of α-globin in ß-thalassemia

    $653k

    Jul 1, 2022NHLBIST. JUDE CHILDREN'S RESEARCH HOSPITALNIH RePORTER · 11125822 (opens the source filing in a new tab)

  4. R01

    Base editing and prime editing for sickle cell disease

    $830k

    Jan 1, 2021NHLBIST. JUDE CHILDREN'S RESEARCH HOSPITALNIH RePORTER · 11228251 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources